These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10761329)

  • 41. Angiogenic protein expression in advanced epithelial ovarian cancer.
    Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
    Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uterine tumours resembling ovarian sex cord tumours: immunohistochemical evidence for true sex cord differentiation.
    McCluggage WG
    Histopathology; 1999 Apr; 34(4):375-6. PubMed ID: 10231408
    [No Abstract]   [Full Text] [Related]  

  • 43. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms.
    Matsumoto Y; Ishiko O; Deguchi M; Nakagawa E; Ogita S
    Int J Mol Med; 2001 Jul; 8(1):31-6. PubMed ID: 11408945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian sclerosing stromal tumor in a young woman with ectopic pregnancy: clinical, pathological, and immunohistochemical studies.
    Liang YF; Zeng JC; Ruan JB; Kang DP; Wang LM; Chen C; Xu JF
    Int J Clin Exp Pathol; 2014; 7(1):456-9. PubMed ID: 24427372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.
    Joo YE; Rew JS; Seo YH; Choi SK; Kim YJ; Park CS; Kim SJ
    J Clin Gastroenterol; 2003 Jul; 37(1):28-33. PubMed ID: 12811205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
    Yamamoto S; Konishi I; Mandai M; Kuroda H; Komatsu T; Nanbu K; Sakahara H; Mori T
    Br J Cancer; 1997; 76(9):1221-7. PubMed ID: 9365173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sclerosing stromal ovarial tumor--a case report and review].
    Popovska S; Popovski K; Gorchev G; Marinov E
    Akush Ginekol (Sofiia); 2005; 44(4):42-5. PubMed ID: 16028379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The expression and significance of VEGF mRNA and bFGF mRNA in the malignant neoplasms of ovary].
    Li L; Liu YZ; Wu YL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):406-8. PubMed ID: 12206019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Aristaless-related homeobox protein in ovarian sex cord-stromal tumors.
    Knific T; Frković Grazio S; Rižner TL
    Exp Mol Pathol; 2018 Feb; 104(1):38-44. PubMed ID: 29275192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool.
    Costa MJ; Ames PF; Walls J; Roth LM
    Hum Pathol; 1997 Nov; 28(11):1247-54. PubMed ID: 9385929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The morphologic and immunohistochemical spectrum of 16 cases of sclerosing stromal tumor of the ovary.
    Qureshi A; Raza A; Kayani N
    Indian J Pathol Microbiol; 2010; 53(4):658-60. PubMed ID: 21045387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Borre M; Nerstrøm B; Overgaard J
    Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sclerosing stromal tumor of the ovaries overexpressing vascular endothelial growth factor: two cases.
    Hirakawa T; Kawano Y; Tsuno A; Nasu K; Narahara H
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):296-8. PubMed ID: 27125419
    [No Abstract]   [Full Text] [Related]  

  • 57. Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis.
    Banerjee SK; Sarkar DK; Weston AP; De A; Campbell DR
    Carcinogenesis; 1997 Jun; 18(6):1155-61. PubMed ID: 9214597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sclerosing stromal tumor of the ovary: MR-pathologic correlation in three cases.
    Kim JY; Jung KJ; Chung DS; Kim OD; Lee JH; Youn SK
    Korean J Radiol; 2003; 4(3):194-9. PubMed ID: 14530650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients.
    Mazzucchelli R; Montironi R; Santinelli A; Lucarini G; Pugnaloni A; Biagini G
    Prostate; 2000 Sep; 45(1):72-9. PubMed ID: 10960845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
    Kojima H; Shijubo N; Abe S
    Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.